The Use of ERCP Versus MRCP in Primary Sclerosing Cholangitis.
作者信息
Enns Robert
机构信息
Clinical Associate Professor University of British Columbia, Vancouver St. Paul's Hospital and Pacific Gastro Associates, Vancouver, Canada.
出版信息
Gastroenterol Hepatol (N Y). 2008 Dec;4(12):852-4.
Abstract
摘要
相似文献
1
The Use of ERCP Versus MRCP in Primary Sclerosing Cholangitis.
Gastroenterol Hepatol (N Y). 2008 Dec;4(12):852-4.
2
The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis.
Endoscopy. 2007 Mar;39(3):222-8. doi: 10.1055/s-2007-966253.
3
Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Endoscopy. 2008 Sep;40(9):739-45. doi: 10.1055/s-2008-1077509. Epub 2008 Aug 12.
4
The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Liver Int. 2018 Dec;38(12):2329-2339. doi: 10.1111/liv.13899. Epub 2018 Jul 18.
5
Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Abdom Radiol (NY). 2020 Aug;45(8):2388-2399. doi: 10.1007/s00261-020-02572-w.
6
Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Endoscopy. 2002 Dec;34(12):984-90. doi: 10.1055/s-2002-35830.
7
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Aliment Pharmacol Ther. 2018 Jul;48(2):169-178. doi: 10.1111/apt.14797. Epub 2018 May 9.
8
Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.
Radiology. 2010 Aug;256(2):387-96. doi: 10.1148/radiol.10091953.
9
MRCP versus ERCP in the diagnosis of primary sclerosing cholangitis.
Gastrointest Endosc. 2007 Mar;65(3):558; author reply 558. doi: 10.1016/j.gie.2006.09.022.
10
Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.
Radiographics. 2000 Jul-Aug;20(4):959-75; quiz 1108-9, 1112. doi: 10.1148/radiographics.20.4.g00jl04959.
引用本文的文献
1
Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 7.
2
Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.
Insights Imaging. 2015 Dec;6(6):665-77. doi: 10.1007/s13244-015-0436-7. Epub 2015 Oct 6.
本文引用的文献
1
Endoscopy in the management of primary sclerosing cholangitis.
Curr Gastroenterol Rep. 2008 Apr;10(2):177-85. doi: 10.1007/s11894-008-0040-9.
2
The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis.
Endoscopy. 2007 Mar;39(3):222-8. doi: 10.1055/s-2007-966253.
3
Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.
Gastrointest Endosc. 2006 Aug;64(2):219-23. doi: 10.1016/j.gie.2005.12.034.
4
Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.
Hepatology. 2004 Jul;40(1):39-45. doi: 10.1002/hep.20287.
5
Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis.
AJR Am J Roentgenol. 2002 Feb;178(2):327-34. doi: 10.2214/ajr.178.2.1780327.
Zotero 插件